跳至主要内容
临床试验/NCT04250675
NCT04250675已完成不适用

Intermittent Pneumatic Compression to Improve the Outcome of Revascularization for Severe Peripheral Artery Disease: a Pilot Study

Indiana University2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
2
主要终点
Walking Endurance

研究概览

简要总结

The purpose of this study is to investigate whether daily treatment with intermittent pneumatic leg compressions (IPC) following a nonsurgical vascular procedure improves circulation and enhances walking distance.

详细描述

Restenosis following revascularization procedures occur frequently and as early as 3 months after the intervention. There is an urgent need for adjunctive therapies that aid in the improvement of tissue blood flow and consequently relieve pain and improve functional capacity in these patients. It has been previously shown that exposure to IPC enhances leg blood flow to collateral-dependent tissues. In this study, subjects who have undergone nonsurgical revascularization will be randomly assigned to two groups: IPC or placebo pump. Subjects will receive a commercially available IPC device (Art Assist, ACI Medical, San Marcos, CA) and will apply the treatment at home for 2 hours daily over 3 consecutive months. At 3 time points (pre, 1 and 3 months post procedure) assessments will be performed (hemodynamics, rest pain, calf muscle oxygenation during exercise, walking endurance and quality of life).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Scheduled for endovascular revascularization of one or both lower extremities.

排除标准

  • Chronic kidney disease (eGFR <30 by MDRD or Mayo or Cockcroft-Gault formula)
  • Open and/or non-healing wounds in the areas covered by IPC cuff
  • Walking limited by a symptom other than PAD
  • Presence of any clinical condition that makes the patient unsuitable to participate in the trial
  • Concern for inability of the patient to comply with study procedures and/or follow-up

结局指标

主要结局

Walking Endurance

时间窗: Baseline and after 1 and 3 months of treatment

Change in 6 Minute Walk Test from baseline to 3 months

次要结局

  • Ankle-brachial Index (ABI)(Baseline and after 3 months of treatment)
  • Toe-brachial Index(Baseline and after 1 and 3 months of treatment)
  • Vascular Quality of Life Score (VascuQol)(Baseline and after 1 and 3 months treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raghu Motaganahalli

Associate Professor

Indiana University

研究点 (2)

Loading locations...

相似试验